3 months ago Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse Read More
3 months ago A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination gen Read More
3 months ago Reply to Di Cosimo et al.: Advancing circulating tumor DNA for recurrent breast cancer Read More
3 months ago Treatment response monitoring using a tumor-informed circulating tumor DNA test in an advanced triple negative breast cancer patient: A case Read More
about 2 years ago Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk Magbanua et al. 2021 NPJ Breast Cancer Read More
over 2 years ago Circulating tumor DNA in neoadjuvant treated breast cancer reflects response and survival Magbanua et al. 2020 Annals of Oncology Read More
about 4 years ago Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence Coombes et al. 2019 Clin. Cancer Res. Read More
about 4 years ago Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients Wi Christensen et al. 2019 J. Clin. Oncol. Read More
3 months ago Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder Read More
5 months ago Molecular Residual Disease and Efficacy of Adjuvant Chemotherapy in Patients with Colorectal Cancer Read More
6 months ago Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair d Read More
6 months ago DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy Read More
3 months ago Early detection of circulating tumor DNA post-operatively enables discovery of resectable metastatic disease in a patient with colon cancer Read More
6 months ago Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Effic Read More
3 months ago A multicenter, prospective observational study to evaluate the impact of circulating tumor DNA guided therapy on patients with colorectal ca Read More
almost 2 years ago Detection of molecular residual disease using personalized circulating tumor DNA assay in colorectal cancer patients undergoing resection of Loupakis et al. 2021 JCO-PO Read More
almost 2 years ago ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in metastatic microsatellite stable colo... Schneider et al. 2021 Case reports in Onc. Read More